France Considering Ban on Disposable E-Cigarettes

May.04.2023
France Considering Ban on Disposable E-Cigarettes
France may ban disposable e-cigarettes by the end of 2023 as part of an anti-smoking plan.

On May 3rd, French Minister of Health François Braun announced that the government may ban disposable e-cigarettes by the end of this year.


Broun expressed his support for the ban on disposable e-cigarettes in an interview with Radio France Inter.


He added,


These devices "are leading some of our young people to use tobacco". "Smoking is a scourge, causing 75,000 deaths in France every year".


François Braun, (source of the picture: lunion)


Braun stated that despite not having a majority in the French parliament, the health ministers will "work with legislators" to reach an agreement on the ban. This ban could be implemented by "the end of this year (2023)" and will be part of the health department's "new anti-smoking plan" for the next five years.


Despite current regulations in France prohibiting the sale of electronic cigarettes to minors, critics are pointing out that about 20 brands of these products are being marketed in a way that appeals to young people. These critics claim that brightly colored packaging and affordable prices (ranging from 8-12 euros or approximately 61.1-91.7 RMB for a 500 puffs product) make the products tempting and accessible to underage buyers.


The French National Assembly recently passed a bill known as the No. 1006 Bill, which legally defines terms such as "business influence activities," "influencers," and "influencer proxies." As per the No. 96 amendment's ban on tobacco and e-cigarette promotions, France will prohibit "influential individuals" from advertising e-cigarettes.


By the end of 2022, the anti-smoking organization ACT stated that disposable vaping devices "are becoming increasingly popular on social media, with a mostly positive and harmless image among young people.


According to ACT, these disposable e-cigarettes may contain up to 20mg of highly addictive nicotine per milliliter, making them a potential "on-ramp" to smoking.


Further reading:


France prohibits influential people from advertising e-cigarettes.


The CBD market in France has reached a size of 500 million Euros and is made up of 2,000 retail stores.


ELFBAR entered the French market in February and plans to sell in 4,000 retail stores.


Reference:


The government of France is considering a prohibition of disposable e-cigarettes.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
The UK High Court has granted U.S. e-cigarette manufacturer Juul Labs a permanent injunction against four Chinese companies, bringing an end to a five-year patent and trademark infringement case. The defendants — Greensun Technology, Ouch, Gaish, and Airsmo Tech — failed to respond to any court communications or legal filings.
Oct.30 by 2FIRSTS.ai
Spain’s Vape Bill Clears EU Internal Market Review, Moves to Parliament
Spain’s Vape Bill Clears EU Internal Market Review, Moves to Parliament
Spain’s draft reform of its tobacco law has reached a critical stage. 2Firsts recently confirmed with Spanish government sources that the bill has completed the EU’s internal market review process and was approved by the Council of Ministers in early September. The decision means that, despite objections from the European Commission and several member states, Spain maintained its original provisions and has now moved the draft into parliamentary debate.
Sep.30
Ukraine Military Voices Concern Over Potential Vape and Pouch Ban
Ukraine Military Voices Concern Over Potential Vape and Pouch Ban
Verkhovna Rada is reviewing six bills to regulate new nicotine products such as pouches and vapes. The main bill, No.14110, proposes a total ban on production, import, and sale, while alternative proposals seek regulation instead of prohibition.
Nov.10 by 2FIRSTS.ai
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
Special Report | After the Shortage: How the U.S. Vape Market Is Rebuilding Itself
After a wave of regulatory crackdowns, the U.S. vaping market is undergoing a deep reshuffle — shortages sparked frenzy, and resupply triggered elimination. Through interviews with industry insiders from both China and the United States, 2Firsts reveals how the American market is rebuilding itself amid turbulence.
Nov.12
Bhutan to Impose 115% Tax on E-cigarettes Starting January 2026
Bhutan to Impose 115% Tax on E-cigarettes Starting January 2026
The Ministry of Health (MoH) of Bhutan has announced stronger actions to combat the growing threat of e-cigarette use, especially among youth. While no new vaping-related lung collapse cases have been reported since 2024, the MoH confirmed that fiscal and legal reforms are underway to include e-cigarettes in tax and tobacco control laws starting January 2026.
Nov.05 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai